Nordic Business Report-April 12, 2006-BioInvent AB reports Q1 operating loss of SEK30.88m
(C)1994-2006 M2 COMMUNICATIONS LTD http://www.m2.com
The Swedish pharmaceuticals developer BioInvent AB issued its first quarter report on Wednesday (12 April), posting an operating loss of SEK30.88m, as compared to a loss of SEK26.86m in the first quarter of 2005.
The net turnover for the period amounted to SEK7.1m, as compared to SEK9.6m in the corresponding period last year.
One Swedish krona (SEK) is worth approximately 0.07 British pounds (GBP).
((Comments on this story may be sent to email@example.com))